Patriot Financial Group Insurance Agency, LLC Angion Biomedica Corp. Transaction History

Patriot Financial Group Insurance Agency, LLC

  • $720 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 20, 2023
BUY
$0.48 - $1.02 $1,440 - $3,060
3,000 Added 13.95%
24,500 $14,000
Q4 2022

Jan 17, 2023
SELL
$0.8 - $1.0 $12,000 - $15,000
-15,000 Reduced 41.1%
21,500 $0
Q2 2022

Jul 29, 2022
BUY
$1.1 - $2.23 $3,300 - $6,690
3,000 Added 8.96%
36,500 $41,000
Q1 2022

May 11, 2022
BUY
$1.72 - $2.96 $57,620 - $99,160
33,500 New
33,500 $71,000

About Angion Biomedica Corp.

ANGN Quotes by TradingView
  • Ticker ANGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,113,300
  • Description
  • Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...
More about ANGN
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email